Antimicrobial switch therapy in pediatric patients hospitalized by uncomplicated community-acquired pneumonia

Código QR

Antimicrobial switch therapy in pediatric patients hospitalized by uncomplicated community-acquired pneumonia

Objective: To evaluate the duration of intravenous (IV) antibiotic therapy and the practice of switch therapy to oral in the treatment of children aged 2 months to 5 years with uncomplicated severe community acquired pneumonia (CAP) in a pediatric public hospital. Methods: Retrospective, observatio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ronaldo MORALES-JUNIOR, Anna C. BARRIENTOS, Raquel M. SCALCO, Aline G. FEVEREIRO, Sulim ABRAMOVICI, Camila C. CAMPIONI
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2020
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/ce3a9e0544bc47b19bd712f56576d9ba
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prescription and administration errors of antimicrobials in a pediatric inpatient unit
por: Gabriela M. MEIRA, et al.
Publicado: (2020)

Comparison of Short- versus Long-Course Antimicrobial Therapy of Uncomplicated Bacterial Pneumonia in Dogs: A Double-Blinded, Placebo-Controlled Pilot Study
por: Aida I. Vientós-Plotts, et al.
Publicado: (2021)

Construction and evaluation of medication reconciliation instruments for pediatric patients
por: Diana Domingues Da Camara Graça, et al.
Publicado: (2019)

Evaluation of the Impact of Antimicrobial Stewardship Program (ASP) on Unrestricted Use of Meropenem at an Academic Medical Center
por: Priyam Mithawala, et al.
Publicado: (2019)

Economic impact of pharmaceutical interventions on healthcare services from Brazil: a systematic review
por: Gustavo B. TIGUMAN, et al.
Publicado: (2020)

Antimicrobial related problems in patients undergoing renal dialysis in a university hospital
por: Cristiane C. Santos, et al.
Publicado: (2020)

Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia
por: Ines Lakbar, et al.
Publicado: (2021)

Naloxone as a trigger to identify opioid-related adverse events in pediatric intensive care units
por: Haline Ogata, et al.
Publicado: (2020)

Design, synthesis, and molecular docking of cysteine-based sulphonamide derivatives as antimicrobial agents
por: Melford C Egbujor, et al.
Publicado: (2022)

Implantação e estruturação do serviço de farmácia clínica em um hospital psiquiátrico da rede pública de saúde
por: Georgia C. COUTINHO, et al.
Publicado: (2021)

Switch therapy da associação de ampicilina e sulbactam em complexo hospitalar do sul do Brasil
por: Camilla M. GOMES, et al.
Publicado: (2021)

Medication reconciliation in pediatric patients with cancer at Brazilian public hospital
por: Nathalia S. PENHA, et al.
Publicado: (2020)

Antimicrobial prescribing and outcomes of community-acquired pneumonia in Australian hospitalized patients: a cross-sectional study
por: Lawless Robert, et al.
Publicado: (2021)

Factors associated with the high medication regimen complexity index in pediatric patients with chronic renal disease
por: Amanda M. PAIVA, et al.
Publicado: (2020)

Prescription errors and administration of injectable antimicrobials in a public hospital
por: Ionara Vieira Rocha Da Mota, et al.
Publicado: (2019)

Histopathologic correlation of Aspergillus endophthalmitis following uncomplicated cataract surgery
por: Haddock LJ, et al.
Publicado: (2012)

Resistance to antimicrobials and vancomycin treatment in neonatal sepsis in a hospital in Brazil
por: Rafael H. SILVEIRA, et al.
Publicado: (2020)

Antimicrobial therapy in older adults: profile of use and evaluation of the quality of prescription
por: Luana F. CRUZ, et al.
Publicado: (2020)

Prediction of Acquired Antimicrobial Resistance for Multiple Bacterial Species Using Neural Networks
por: D. Aytan-Aktug, et al.
Publicado: (2020)

Nanotechnology-Based Delivery Systems for Antimicrobial Peptides
por: Adewale Oluwaseun Fadaka, et al.
Publicado: (2021)

Severity factors of Acquired Pneumonia Community in a children's hospital in the Colombian Caribbean
por: Suanny González-Coquel, et al.
Publicado: (2018)

Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients
por: Ugajin M, et al.
Publicado: (2014)

Small doses of a great challenge: 26 recommendations for pediatric pharmaceutical services in Brazil
por: Rafael Santos Santana, et al.
Publicado: (2019)

Detection of respiratory viral and bacterial pathogens causing pediatric community-acquired pneumonia in Beijing using real-time PCR
por: Tie-Gang Zhang, et al.
Publicado: (2015)

Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients
por: A. Premachandra, et al.
Publicado: (2021)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
por: Sara Salvador-Martín, et al.
Publicado: (2021)

Biocompatibility and Antimicrobial Activity of Nanostructured Lipid Carriers for Topical Applications Are Affected by Type of Oils Used in Their Composition
por: Dragana P. C. de Barros, et al.
Publicado: (2021)

Clinically relevant drug interactions involving antimicrobials in a general hospital: a cross-sectional study
por: Larissa PAVANELLO, et al.
Publicado: (2021)

Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
por: Joonhyeok Choi, et al.
Publicado: (2021)

Management of Community acquired pneumonia in the Emergency Room
por: Eduardo Esteban-Zubero, et al.
Publicado: (2019)

FEATURES OF IMMUNE DISTURBANCES IN COMMUNITY-ACQUIRED PNEUMONIAS
por: G. A. Mavziutova, et al.
Publicado: (2014)

An unusual non-resolving community-acquired pneumonia
por: Andrea Zappalà, et al.
Publicado: (2021)

A complicated case of community-acquired pneumonia
por: Ana Rita Parente, et al.
Publicado: (2021)

The effectiveness of moxifloxacin in the treatment of community-acquired pneumonia
por: Dmytro Dmytriiev, et al.
Publicado: (2021)

Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae
por: Xiaoling Su, et al.
Publicado: (2021)

Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens
por: Trudy H. Grossman, et al.
Publicado: (2017)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
por: Kashif Hussain, et al.
Publicado: (2021)

Epidemiology, etiology, and diagnosis of health care acquired pneumonia including ventilator-associated pneumonia in Nepal.
por: Sabina Dongol, et al.
Publicado: (2021)

Epidemiology, etiology, and diagnosis of health care acquired pneumonia including ventilator-associated pneumonia in Nepal
por: Sabina Dongol, et al.
Publicado: (2021)

Prospects for using Origanum Syriacum (L.) as a source of antimicrobial agents
por: Ranim Mohamad, et al.
Publicado: (2021)